Clinical trial population adjacent: Obese individuals with higher adiposity, MASLD, T2D/high HbA1c, and/or significant liver fat and metabolic panel improvement goals
FDA announced the approval of Novo Nordisks blockbuster type 2 diabetes treatment, semaglutide, sold under the brand name Ozempic
Patients should seek immediate medical attention for severe, persistent abdominal pain while taking these medications, as this could indicate pancreatitis
Together, we will determine the best approach based on your health goals, lifestyle, and current needs.
The medication is available in all 50 states with no insurance required, and qualifies for HSA and FSA accounts